Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use

US7989472B2 · kind B2 · utility

Assignee

• Merck Sharp & Dohme LLC · US

Inventors

• Ronald Kim · Essen, DE
• Emma R. Parmee · Scotch Plains, US
• Qiang Tan · Westfield, US
• Ashley Rouse Lins · Edison, US
• Jiang Chang · Beijing, CN
• Cangming Yang · South River, US

Key dates

• Filing date: Mar 19, 2007
• Grant date: Aug 2, 2011
• Expiry date: Apr 4, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/42
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.